CompoAtlas

Marina G2+

Natural health product licensed in Canada

Other names
Miracol G2+
Licence holder
9002-1957 Quebec Inc.
NPN or DIN-HM
80049264
Status
Active licence
Licence date
17 March 2014
Revision date
25 September 2026
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Urtica dioica

Source : Sommet (pousse)

100 mgNot calculated
Collagène hydrolysé

Source : Poissons -Peau

400 mgNot calculated
Vitamine C

Source : Vitamine C

50 mg150,000 µg
Curcuma longa

Source : Curcuma longa - rhizome

Extraction ratio : 4:1

Dry plant equivalent : 400 mg

100 mgNot calculated
2-hydroxy-1,2,3-acide propanetricarboxylique, sel de magnésium

Source : Citrate de magnésium

100 mgNot calculated
Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose

Source : exosquelettes de crevettes

350 mgNot calculated
Piper nigrum

Source : Piper nigrum - fruit

3 mgNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé3 Tous les jours

Uses authorised in Canada

Fournit des antioxydants pour le maintien d'une bonne santé. Utiliser traditionellement en phytothérapie comme anti-inflammatoire pour aider à soulager la douleur articulaire.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80049264

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line